Metabolic Disease
News on research and diagnostics for metabolic disorders and metabolic diseases.
Alere and Former Diabetic Testing Subsidiary Settle False Claims Allegations for $160M
Now-defunct Arriva Medical and its parent company Alere were accused of paying kickbacks to Medicare beneficiaries.
The French biotech company has indicated that it will likely create a wholly owned subsidiary that will house its diagnostics work.
Renalytix AI Lands US Government Contract for Kidney Disease Test
The firm said that the contract covers early-stage kidney disease testing that can be provided by more than 140 US government departments, agencies, and affiliates.
Bio-Techne expects the acquisition will provide it with a basis to build out its IVD presence, given Asuragen's diagnostic tests and regulatory expertise.
RenalytixAI Reports Q2 2021 Revenues of $400K
For the three months ended Dec. 31, 2020, the firm reported $400,000 in pharmaceutical service revenue compared to none in 2019.